Early access
Sign in
Not yet taking people in ItalyPhase 1

Testing Oncofid-P-M given into the chest cavity for pleural mesothelioma that has come back

Tests different doses of Oncofid-P-M in adults with pleural mesothelioma that returned or progressed.

Key facts

Who runs it
Fidia Farmaceutici S.p.A.
Where
Padova, ItalySee the site
Registry title
A Phase I dose escalation study of intrapleural administration of Oncofid-P-M in patients with unresectable recurrent/progressive pleural mesothelioma after first-line treatment
Status
Not yet recruiting
Phase
Phase 1
People taking part
30 people, planned
Started
1 Sept 2026
Expected to end
31 Dec 2030
Type of study
Interventional
Record updated
16 September 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with pleural mesothelioma that cannot be removed by surgery and has come back or is getting worse after first-line treatment.

Age
18 years or older
Sex
Women and men can join.
Disease stage
Pleural mesothelioma that cannot be removed by surgery and has come back or is progressing.
Earlier treatment
Must have had first-line treatment already.

Where in Italy

  • Istituto Oncologico VenetoPadova, ItalyNot yet recruiting

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).
Plain-language title
Testing Oncofid-P-M given into the chest cavity for pleural mesothelioma that has come backGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 9 November 2026.
Record updated
16 September 2026